Fiji Kava

Established in WA: 2018
c/o Cicero Suite 9, 330 Churchill Avenue, SUBIACO, 6008
08 6489 1600

Notable People

NamePositionYear Started
Andrew Kelly
Andrew Kelly
Non-Executive Chair2019
Zane Yoshida
Zane Yoshida
Managing Director2019
Stephen Copplin
Stephen Copplin
Executive Director2019
Jay Stephenson
Jay Stephenson
Non-Executive Director, Company Secretary2019
* Most Senior WA Executive

ECM Deals

DateCompanyTransaction TypeTotal Value
19/12/18Fiji KavaInitial public offering$5.2m>>


Fiji Kava is a kava company based in Australia and the first foreign company with approval from the Fijian Government to operate in the kava industry. The Company has complete control over its vertically integrated supply chain in a true farm-to-shelf operation and has established a 111-acre nucleus farm in Levuka, on the island of Ovalau, Fiji.

Fiji Kava is focused on expanding the distribution of kava throughout western markets to provide a natural alternative to anti-anxiety prescription medicines such as Valium and Xanax. The Company sells its range of TGA and FDA compliant “Taki Mai”branded kava products in Fiji and is preparing to launch under the Fiji Kava brand in Australia in early 2019.
Biography last updated 27 Jan 2019

Fiji Kava (FIJ)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BNiQ Disclaimer